Literature DB >> 15337618

Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.

Makoto Sohmiya1, Makoto Tanaka, Nyou Wei Tak, Makoto Yanagisawa, Yutaka Tanino, Yoko Suzuki, Koichi Okamoto, Yorihiro Yamamoto.   

Abstract

Oxidative stress is suggested to play an important role in the pathogenesis of Parkinson's disease (PD). However, no elevation of plasma oxidative stress marker has been reported. We measured percent content of the oxidized form of coenzyme Q10 in total coenzyme Q10 (%CoQ-10) because %CoQ-10 has been shown to be a sensitive marker of oxidative stress. A slight but significant elevation in %CoQ-10 was observed in PD patients when compared with age/gender-matched normal subjects, suggesting elevated systemic oxidative stress in PD patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15337618     DOI: 10.1016/j.jns.2004.05.007

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  40 in total

Review 1.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

Review 2.  LXR agonists: new potential therapeutic drug for neurodegenerative diseases.

Authors:  Pei Xu; Dabing Li; Xiaotong Tang; Xiaohang Bao; Jing Huang; Yongping Tang; Yang Yang; Haiwei Xu; Xiaotang Fan
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

3.  Coenzyme q10 therapy.

Authors:  Juan Garrido-Maraver; Mario D Cordero; Manuel Oropesa-Ávila; Alejandro Fernández Vega; Mario de la Mata; Ana Delgado Pavón; Manuel de Miguel; Carmen Pérez Calero; Marina Villanueva Paz; David Cotán; José A Sánchez-Alcázar
Journal:  Mol Syndromol       Date:  2014-07

Review 4.  Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.

Authors:  Lijun Dai; Li Zou; Lanxia Meng; Guifen Qiang; Mingmin Yan; Zhentao Zhang
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

Review 5.  Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.

Authors:  Chun Zhou; Yong Huang; Serge Przedborski
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

6.  Coenzyme Q10 effects in neurodegenerative disease.

Authors:  Meredith Spindler; M Flint Beal; Claire Henchcliffe
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570

7.  Do mtDNA Mutations Participate in the Pathogenesis of Sporadic Parkinson's Disease?

Authors:  E Kirches
Journal:  Curr Genomics       Date:  2009-12       Impact factor: 2.236

8.  Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease.

Authors:  Zhiyin Xun; Renã A Sowell; Thomas C Kaufman; David E Clemmer
Journal:  Mol Cell Proteomics       Date:  2008-03-18       Impact factor: 5.911

9.  Coenzyme Q10: is there a clinical role and a case for measurement?

Authors:  Sarah L Molyneux; Joanna M Young; Christopher M Florkowski; Michael Lever; Peter M George
Journal:  Clin Biochem Rev       Date:  2008-05

10.  Stable isotope labeling and label-free proteomics of Drosophila parkin null mutants.

Authors:  Zhiyin Xun; Thomas C Kaufman; David E Clemmer
Journal:  J Proteome Res       Date:  2009-10       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.